This website uses cookies to improve your experience and analyze site traffic. You can read more about our cookie and privacy policy by here.
Accept
Author: rvacdev
-
August 18, 2022
Rational Vaccines Announces a Clinical Trial to Determine Baseline Characteristics of Patients Diagnosed With Recurrent Symptomatic Herpes Simplex Type 2 (HSV-2) Virus
-
July 9, 2022
Rationals Experimental Herpes Vaccine Shows Preclinical Promise
-
July 8, 2022
Rational’s Experimental Herpes Vaccine Shows Preclinical Promise
-
June 10, 20222022 BIO International Convention
-
June 10, 2022
The Major Breakthrough That Completely Stopped This Woman’s Painful Genital Herpes Outbreaks
-
January 3, 2022
Biotech Showcase
-
December 14, 2021
RVx201 Herpes Vaccine — Precision Vaccinations
-
November 16, 2021
Jeffries London Healthcare Conference
-
July 26, 2021
A Rationally Designed Therapeutic Vaccine for Herpes
-
April 10, 2021
Meet Rational’s Dr. Gus Kousoulas
